Mounjaro vs Wegovy UK: Price, Efficacy & Differences 2025

Clinically Proven UK Registered Pharmacy

Wegovy vs Mounjaro: Key Differences & UK Pricing

UK-registered clinical team
Confidential and secure
No GP visit needed
Fast and discreet delivery
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £10 off for new customers
Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment
£145.00 From £135.00 £10 discount using discount code Weightlossnew
LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £135.00

£36.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £169.00

£44.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £210.00

£55.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £235.00

£61.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £260.00

£67.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £277.00

£71.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £79.00

£22.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £99.00

£27.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £109.00

£29.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £159.00

£42.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £189.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation

Wegovy vs Mounjaro: Key Differences & UK Pricing

If you're researching a mounjaro vs wegovy uk price comparison, you're likely weighing two of the most effective prescription weight loss treatments available today. Both are weekly injectable medications licensed by the MHRA, but they differ in active ingredient, mechanism of action, clinical efficacy, and cost. At Cured Pharmacy, we provide transparent pricing, UK prescriber consultations, and discreet delivery for both treatments, helping you make an informed choice based on clinical evidence and your individual health profile.

Mounjaro vs Wegovy UK: Active Ingredients and Mechanisms

Mounjaro contains tirzepatide, the UK's first dual GIP/GLP-1 receptor agonist, meaning it activates two hormone pathways that regulate appetite, blood sugar, and energy metabolism [1]. Wegovy, by contrast, contains semaglutide, a single GLP-1 receptor agonist that has been widely studied and used in the UK since 2022 [2].

The dual-action mechanism of tirzepatide distinguishes Mounjaro from all other currently licensed weight loss injections. By targeting both glucose-dependent insulinotropic polypeptide (GIP) receptors and glucagon-like peptide-1 (GLP-1) receptors, Mounjaro produces more pronounced reductions in appetite and body weight in clinical trials compared to single-pathway treatments [1][3].

Both medications are administered as once-weekly subcutaneous injections using pre-filled pens. Each requires gradual dose escalation over several weeks to minimise gastrointestinal side effects, and both are prescription-only medicines in the UK, requiring clinical assessment by a registered prescriber before dispensing.

Clinical Efficacy: Mounjaro vs Wegovy Weight Loss Results

In head-to-head comparisons and separate large-scale trials, Mounjaro has demonstrated superior weight loss outcomes. The SURMOUNT-1 trial showed that adults using the highest dose of tirzepatide (15 mg) achieved an average weight reduction of 22.5% over 72 weeks, compared to placebo [1]. The STEP 1 trial, which evaluated semaglutide 2.4 mg (Wegovy), reported an average weight loss of 14.9% over 68 weeks [2].

A direct comparison study published in 2024 confirmed tirzepatide's greater efficacy: patients on Mounjaro lost approximately 6% more body weight on average than those on Wegovy after one year of treatment [3]. Both treatments, however, significantly outperform older weight loss medications and lifestyle interventions alone.

Individual results vary based on baseline weight, adherence to treatment, dietary habits, physical activity, and metabolic factors. Your UK prescriber will assess your medical history, current medications, and weight loss goals to determine which treatment may be more suitable for you.

Who Responds Best to Each Treatment?

Clinical trials indicate that both Mounjaro and Wegovy are effective across a broad range of patients with a BMI of 30 or above, or 27 or above with weight-related comorbidities such as type 2 diabetes, hypertension, or sleep apnoea [1][2]. Patients with type 2 diabetes may experience additional glycaemic benefits from tirzepatide due to its dual-receptor action, though both medications improve HbA1c levels.

Those who have previously used liraglutide (Saxenda) or other GLP-1 treatments and experienced suboptimal weight loss may benefit from switching to Mounjaro, given its enhanced mechanism and clinical outcomes. Your prescriber will consider your treatment history, tolerance to GLP-1 side effects, and individual response when recommending a medication.

Mounjaro vs Wegovy UK Pricing and Value

At Cured Pharmacy, Mounjaro is priced from £135.00 per pen, and Wegovy starts from £135.00 per pen, with final costs determined by your prescribed dose following a free online consultation with a UK prescriber. These prices reflect our commitment to transparent, competitive pricing and include clinical assessment, prescription, and discreet UK delivery.

While Mounjaro carries a higher per-pen cost, many patients and prescribers consider the additional investment justified by the greater average weight loss observed in clinical trials. Wegovy remains an excellent option for those seeking effective weight management at a lower price point, particularly if budget is a primary concern or if clinical trials suggest similar efficacy for your profile.

Neither medication is currently available on the NHS for weight management alone in most areas due to supply constraints and commissioning decisions, though exceptions exist for patients with type 2 diabetes or specific clinical criteria. Private prescriptions through registered UK pharmacies like Cured Pharmacy offer reliable access to both treatments without waiting lists.

Feature Mounjaro (Tirzepatide) Wegovy (Semaglutide)
Active Ingredient Tirzepatide (dual GIP/GLP-1 agonist) Semaglutide (GLP-1 agonist)
Average Weight Loss (clinical trials) Up to 22.5% over 72 weeks [1] Up to 14.9% over 68 weeks [2]
Dosing Frequency Once weekly injection Once weekly injection
Starting Price at Cured Pharmacy From £145.00 From £89.00
Common Side Effects Nausea, diarrhoea, vomiting, constipation Nausea, diarrhoea, vomiting, constipation
MHRA Approval for Weight Loss Yes (2023) Yes (2022)
Prescription Required Yes Yes

Side Effects: What to Expect from Mounjaro and Wegovy

Both Mounjaro and Wegovy share a similar side effect profile, as both are GLP-1 receptor agonists. The most commonly reported adverse effects include nausea, diarrhoea, vomiting, constipation, and abdominal discomfort, particularly during the initial dose escalation phase [1][2]. These symptoms typically improve over several weeks as your body adjusts to the medication.

In clinical trials, approximately 10-20% of participants on tirzepatide and 5-15% on semaglutide discontinued treatment due to gastrointestinal side effects [1][2]. Gradual dose titration, eating smaller meals, and avoiding high-fat foods can help minimise these effects. Rare but serious risks include pancreatitis, gallbladder disease, and thyroid C-cell tumours (observed in rodent studies but not confirmed in humans).

Your UK prescriber will review your medical history for contraindications, including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Both medications are contraindicated in pregnancy, and effective contraception is advised during treatment. If you experience persistent vomiting, severe abdominal pain, or signs of pancreatitis, seek immediate medical attention.

Managing Side Effects Effectively

Most patients find that nausea and gastrointestinal symptoms resolve within 4-6 weeks of starting treatment or increasing doses. Eating slowly, choosing bland and low-fat foods, staying well-hydrated, and avoiding large meals can significantly reduce discomfort. If side effects persist or worsen, your prescriber may adjust your dose or recommend an alternative treatment.

Both Mounjaro and Wegovy are generally well-tolerated when used under medical supervision. Our clinical team at Cured Pharmacy, led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073), is available to support you throughout your treatment journey and answer any questions about managing side effects or optimising your results.

How to Start Mounjaro or Wegovy at Cured Pharmacy

Starting treatment with Mounjaro or Wegovy at Cured Pharmacy is straightforward and discreet. Begin by completing our free online consultation, which takes under three minutes and covers your medical history, current medications, weight loss goals, and any contraindications. Your responses are reviewed by a UK-registered prescriber, who will determine whether Mounjaro, Wegovy, or another treatment is suitable for you.

If approved, your prescription is issued electronically and dispensed by our UK-registered pharmacy team. Your medication is packaged discreetly and delivered to your address via secure courier, typically within 1-3 working days. All medications supplied by Cured Pharmacy are genuine, UK-licensed products sourced from reputable manufacturers and stored in accordance with MHRA guidelines.

You will receive clear instructions on how to administer your injections, store your pens, and escalate your dose safely. Our team is available by phone ((+44) 116 4646009) or email to answer any questions before, during, or after your treatment. Follow-up consultations are available to monitor your progress, adjust doses, or switch treatments if needed.

Mounjaro vs Wegovy: Which Should You Choose?

Choosing between Mounjaro and Wegovy depends on your weight loss goals, budget, medical history, and tolerance to GLP-1 medications. If maximising weight loss is your primary objective and you are comfortable with a higher investment, Mounjaro's dual-action mechanism and superior trial outcomes make it a compelling choice [1][3]. If cost is a significant factor or you have previously responded well to single-pathway GLP-1 treatments, Wegovy offers proven efficacy at a more accessible price point [2].

Both medications require commitment to a healthy diet, regular physical activity, and long-term adherence to maintain results. Weight regain is common if treatment is discontinued without ongoing lifestyle modification. Your UK prescriber will discuss realistic expectations, potential side effects, and strategies for sustaining weight loss beyond the medication period.

At Cured Pharmacy, we provide unbiased clinical guidance to help you select the treatment best suited to your individual circumstances. Our transparent pricing, UK-registered clinical team, and commitment to patient safety ensure you receive expert care from consultation through to delivery and beyond.

Combining Treatment with Lifestyle Changes

Both Mounjaro and Wegovy are most effective when combined with a reduced-calorie diet and increased physical activity. Clinical trials demonstrating significant weight loss included structured lifestyle interventions alongside medication [1][2]. Your prescriber may recommend working with a dietitian, joining a weight management programme, or setting specific activity goals to optimise your results.

Long-term success requires sustainable behavioural changes. While these medications reduce appetite and support initial weight loss, maintaining your results depends on continued healthy eating patterns, regular exercise, and ongoing medical support. Our team at Cured Pharmacy is here to support your journey every step of the way.

Scientific References

  1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
  2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
  3. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, dietary modifications, and physical activity levels.

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Is Mounjaro better than Wegovy for weight loss?
Clinical trials show Mounjaro (tirzepatide) produces greater average weight loss than Wegovy (semaglutide), with patients losing approximately 6% more body weight over one year. Individual results vary, and your UK prescriber will recommend the most suitable treatment based on your medical history and goals.
Can I switch from Wegovy to Mounjaro?
Yes, switching from Wegovy to Mounjaro is possible under prescriber supervision. Your clinician will assess your response to semaglutide, current health status, and weight loss goals before transitioning you to tirzepatide with appropriate dose adjustments.
How much does Mounjaro vs Wegovy cost in the UK?
At Cured Pharmacy, Mounjaro starts from £135.00 per pen and Wegovy from £135.00 per pen, with final pricing determined by your prescribed dose. Both prices include clinical consultation, prescription, and discreet UK delivery.
Do Mounjaro and Wegovy have the same side effects?
Both medications share similar side effects, including nausea, diarrhoea, vomiting, and constipation, as they both act on GLP-1 receptors. Most side effects are mild to moderate and improve within several weeks of starting treatment.
Which is more effective: Mounjaro or Wegovy?
Mounjaro has demonstrated superior weight loss efficacy in clinical trials, with average reductions of 22.5% compared to Wegovy's 14.9%. Both are highly effective treatments, and your prescriber will help determine which is best for your individual circumstances.
Can I buy Mounjaro or Wegovy without a prescription in the UK?
No. Both Mounjaro and Wegovy are prescription-only medicines in the UK and require clinical assessment by a UK-registered prescriber before they can be legally dispensed by a pharmacy.
How long does it take to see results with Mounjaro vs Wegovy?
Most patients begin noticing appetite suppression and initial weight loss within 4-8 weeks of starting either medication. Significant weight reduction typically occurs over 6-12 months with continued treatment and lifestyle modifications.
Are Mounjaro and Wegovy available on the NHS?
Availability on the NHS is limited and varies by region due to supply constraints and local commissioning decisions. Most patients access these treatments privately through registered UK pharmacies like Cured Pharmacy, where transparent pricing and fast access are guaranteed.